
[Federal Register Volume 76, Number 244 (Tuesday, December 20, 2011)]
[Notices]
[Page 78931]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-32436]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0885]


Food and Drug Administration Rare Disease Patient Advocacy Day; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration's (FDA) Office of Orphan Products 
Development is announcing the following meeting: FDA Rare Disease 
Patient Advocacy Day. This meeting is intended to enhance the awareness 
of the rare disease community as to FDA's roles and responsibilities in 
the development of products (drugs, biological products, and devices) 
intended for the diagnosis, prevention, and/or treatment of rare 
diseases or conditions. The goal of this meeting is to engage and 
educate the rare disease community on the FDA regulatory processes.
    This educational meeting will consist of a live and interactive 
simultaneous Web cast of presentations provided by FDA experts from 
various Centers and Offices, as well as from outside experts. The 
interactive meeting will include two general panel discussion sessions, 
as well as afternoon breakout sessions for more indepth information on 
the roles of FDA. In addition, onsite attendees will have an 
opportunity during lunch to engage with FDA and outside experts in a 
small group setting.
    Date and Time: The meeting will be held on March 1, 2012, from 8:30 
a.m. to 5 p.m.
    Location: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 
Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993-
0002. For participants who cannot attend the live meeting, a live 
interactive Web cast will be made available. Participants may access 
this live Web cast by visiting the following site: http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/OOPDNewsArchive/ucm277194.htm.
    Contact: Soumya Patel, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 32, Rm.5279, Silver Spring, MD 20993-0002, (301) 
796-8660, FAX: (301) 847-8621, email: FDAadvocacy@fda.hhs.gov.
    Registration: Interested participants may register for this meeting 
at the following Web site: https://www.team-share.net/FDA_Rare_Disease_Patient_Advocacy_Day_Registration.
    If you need sign language interpretation during this meeting, 
please contact Megan McNamee at mmcnamee@icfi.com by February 15, 2012.
    The FDA Rare Disease Patient Advocacy Day is supported by FDA, the 
National Institutes of Health (NIH), the National Organization for Rare 
Disorders, and the Genetic Alliance.
    FDA encourages all attendees to also plan on attending the NIH Rare 
Disease Day day-long celebration on February 29, 2011. Please refer to 
the following Web site for more information regarding the NIH Rare 
Disease Day event: http://rarediseases.info.nih.gov/RareDiseaseDay.aspx. (FDA has verified the Web site addresses 
throughout this document, but we are not responsible for any subsequent 
changes to the Web sites after this document publishes in the Federal 
Register.)

    Dated: December 14, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-32436 Filed 12-19-11; 8:45 am]
BILLING CODE 4160-01-P


